Koh Furuta
Papers
1
Total Citations
35
H-Index
1
About
Dr. Koh Furuta is a leading researcher in pancreatic cancer biology and biomarker discovery, with a particular focus on improving therapeutic outcomes for patients receiving gemcitabine-based chemotherapy. His most cited work, a 2010 study on survival prediction for pancreatic cancer patients, has garnered 35 citations and represents a significant contribution to personalized oncology. In this landmark study, Dr. Furuta employed liquid chromatography-mass spectrometry (LC-MS) to identify novel biomarkers capable of predicting overall survival in patients undergoing gemcitabine monotherapy—a standard but variably effective treatment. By comparing baseline molecular profiles, he addressed the critical clinical challenge of why some patients derive substantial benefit while others do not. His research bridges proteomics and clinical medicine, aiming to spare non-responders from ineffective treatments and guide more tailored therapeutic strategies. Dr. Furuta’s work has been instrumental in advancing the understanding of chemoresistance and patient stratification, making him a respected voice in the field of pancreatic cancer research and precision medicine.
Research Focus
Key Achievements
Top Papers
- 1